Gils A - Search Results

1

Characterization of plasminogen activator inhibitor 1 mutants containing the P13 to P10 region of ovalbumin or antithrombin III: evidence that the P13 residue contributes significantly to the active to substrate transition.

Gils A, Vleugels N, Tobback K, Knockaert I, Declerck PJ. Gils A, et al. Biochim Biophys Acta. 1998 Sep 8;1387(1-2):291-7. doi: 10.1016/s0167-4838(98)00139-3. Biochim Biophys Acta. 1998. PMID: 9748634

2

Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1.

Verheyden S, Sillen A, Gils A, Declerck PJ, Engelborghs Y. Verheyden S, et al. Among authors: gils a. Biophys J. 2003 Jul;85(1):501-10. doi: 10.1016/S0006-3495(03)74495-6. Biophys J. 2003. PMID: 12829505 Free PMC article.

3

The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors.

Gils A, Declerck PJ. Gils A, et al. Thromb Haemost. 2004 Mar;91(3):425-37. doi: 10.1160/TH03-12-0764. Thromb Haemost. 2004. PMID: 14983217 Review.

4

Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.

De Taeye B, Gils A, Vleugels N, Rabijns A, Declerck PJ. De Taeye B, et al. Among authors: gils a. Biochem Biophys Res Commun. 2004 Aug 27;321(3):746-51. doi: 10.1016/j.bbrc.2004.07.023. Biochem Biophys Res Commun. 2004. PMID: 15358169

5

Plasminogen activator inhibitor-1.

Gils A, Declerck PJ. Gils A, et al. Curr Med Chem. 2004 Sep;11(17):2323-34. doi: 10.2174/0929867043364595. Curr Med Chem. 2004. PMID: 15379715 Review.

6

The story of the serpin plasminogen activator inhibitor 1: is there any need for another mutant?

De Taeye B, Gils A, Declerck PJ. De Taeye B, et al. Among authors: gils a. Thromb Haemost. 2004 Nov;92(5):898-924. doi: 10.1160/TH04-05-0269. Thromb Haemost. 2004. PMID: 15543316 Review.

7

Use of mouse models to study plasminogen activator inhibitor-1.

Declerck PJ, Gils A, De Taeye B. Declerck PJ, et al. Among authors: gils a. Methods Enzymol. 2011;499:77-104. doi: 10.1016/B978-0-12-386471-0.00005-5. Methods Enzymol. 2011. PMID: 21683250

8

Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin.

Declerck PJ, Gils A. Declerck PJ, et al. Among authors: gils a. Semin Thromb Hemost. 2013 Jun;39(4):356-64. doi: 10.1055/s-0033-1334487. Epub 2013 Mar 16. Semin Thromb Hemost. 2013. PMID: 23504606 Review.

9

Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.

Gils A, Knockaert I, Declerck PJ. Gils A, et al. Biochemistry. 1996 Jun 11;35(23):7474-81. doi: 10.1021/bi960079d. Biochemistry. 1996. PMID: 8652525

10

Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1.

Gils A, Declerck PJ. Gils A, et al. J Biol Chem. 1997 May 9;272(19):12662-6. doi: 10.1074/jbc.272.19.12662. J Biol Chem. 1997. PMID: 9139722 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters